ESMO Advanced Course on Breast Cancer: Filling the Gaps Following Progression on CDK4/6 in Hormone Receptor Positive HER2 Negative Advanced Breast Cancer 2024: Doha

Learning objectives

• Understanding the function and biology of CDK4/6 in breast cancer
• Information and in-depth discussion on the state of the art and emerging therapeutic strategies integrating CDK4/6 inhibition in breast cancer, both in the early and metastatic setting
• Assessing the clinical and genomic features for risk of relapse in early HR+/HER2 negative breast cancer
• Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of CDK4/6 inhibition
• Discussing clinical cancer cases to integrate use of CDK4/6 inhibitors in clinical practice

Download the preliminary programme

Co-Chairs:

• Nadia Harbeck, Germany
• Salha Bujassoum, Qatar

Participants

This is a closed course reserved to invited Middle East participants.

What's included?

Participants will benefit from complimentary course registration and accommodation. Travel will be covered as well.

Accreditation

The programme of this event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements

Health and Safety Policy

It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.

During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.

In general, ESMO recommends:

• to apply health precautions and measures according to formal guidance and personal medical history
• to stay up to date with the vaccination status
• to perform a Rapid Antigen Test and wear a mask in case of symptoms

Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.

Any changes to the ESMO health and safety protocols will be communicated on this webpage.

Insurance

ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage.

Venue

Doha, Qatar